Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Investor Overview

Events & Presentations

Analyst Coverage

Firm Analyst
Oppenheimer & Co.
Mark Breidenbach Ph.D.
Piper Jaffray & Co
Tyler Van Buren
RBC Capital Markets
Kennen MacKay Ph.D.

Stock Information

Copyright West LLC. Minimum 15 minutes delayed.